List view / Grid view

Drug Supply Chain

 

Expert view: The QC micro labs have grown to tackle new challenges

29 October 2018 | By Charles River

Timelines, budgets and regulatory constraints have grown alongside that of the Quality Control (QC) lab’s position in drug development. The main goal of the lab and more widely of the manufacturing industry is to increase safety for the end user and guarantee patients’ health...

Understanding the complexities of global serialisation & traceability regulations

18 September 2018 | By Clarivate Analytics

In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 per cent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market…